{
    "clinical_study": {
        "@rank": "102329", 
        "arm_group": {
            "arm_group_label": "Red Bull\u2122 Sugar-Free Drink", 
            "arm_group_type": "Experimental", 
            "description": "Red Bull\u2122 Sugar-Free Drink: two (250mL) cans per day for 28 days"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this research study is to find out if Red Bull\u2122 Sugar-Free Drink can reduce\n      fatigue in prostate cancer patients receiving LHRH agonist therapy."
        }, 
        "brief_title": "Study of Red Bull\u2122 Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy", 
        "condition": "Fatigue", 
        "condition_browse": {
            "mesh_term": [
                "Fatigue", 
                "Prostatic Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed prostate cancer\n\n          -  Currently receiving LHRH-agonist therapy for greater than 6 months\n\n          -  Measurable fatigue, defined as a score of \u2265 2 on the Bruera global fatigue severity\n             scale\n\n          -  Able to swallow Red Bull\u2122 Sugar-Free Drink\n\n          -  Life expectancy of at least 1 year\n\n          -  Able to read and write in English\n\n          -  Willing to limit consumption of alcohol to one drink per day\n\n        Exclusion Criteria:\n\n          -  Current malignancy or received treatment for a previous malignancy within the last 3\n             years other than prostate cancer (exceptions are superficial bladder cancer or\n             non-melanoma skin cancer)\n\n          -  Myocardial infarction within past 6 months\n\n          -  Any unstable serious co-existing medical condition(s) including but not limited to\n             unstable or poorly controlled coronary artery disease, chronic atrial fibrillation,\n             uncontrolled hypertension, uncontrolled diabetes, severe bleeding diseases or immune\n             disorders\n\n          -  Evidence of drug or alcohol abuse\n\n          -  Known hypersensitivity to caffeine\n\n          -  Known history of liver and kidney insufficiencies\n\n          -  Known contraindications to Red Bull\u2122 use"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669460", 
            "org_study_id": "12-5041-C"
        }, 
        "intervention": {
            "arm_group_label": "Red Bull\u2122 Sugar-Free Drink", 
            "description": "Red Bull\u2122 Sugar-Free Drink two (250mL) cans per day for 28 days", 
            "intervention_name": "Red Bull\u2122 Sugar-Free Drink", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5T 1C1"
                }, 
                "name": "University Health Network"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase II, Open Label Study of Red Bull\u2122 Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy", 
        "overall_official": {
            "affiliation": "University Health Network, Toronto", 
            "last_name": "Neil Fleshner, MD, FRCSC, MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: University Health Network Research Ethics Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Reduction in overall fatigue as measured by Bruera global fatigue severity scale.", 
            "safety_issue": "No", 
            "time_frame": "Within 4 days after completion of intervention (28 days of Red Bull\u2122)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669460"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Overall improvement in quality of life as measured by the Medical Outcomes Study Short-Form (SF-36)", 
            "safety_issue": "No", 
            "time_frame": "Within 4 days after completion of intervention (28 days of Red Bull\u2122)"
        }, 
        "source": "University Health Network, Toronto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Health Network, Toronto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}